$WYY
WIDEPOINT CORP

2023 Q3 Form 10-Q Financial Statement

#000165495423010759 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $25.73M $26.76M
YoY Change 1.83% 16.07%
Cost Of Revenue $21.84M $22.85M
YoY Change 1.71% 15.78%
Gross Profit $3.895M $3.910M
YoY Change 2.51% 17.77%
Gross Profit Margin 15.14% 14.61%
Selling, General & Admin $4.468M $4.373M
YoY Change 8.36% -0.17%
% of Gross Profit 114.71% 111.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $780.0K $771.7K
YoY Change 186.55% 181.56%
% of Gross Profit 20.03% 19.74%
Operating Expenses $4.728M $4.636M
YoY Change 7.56% -77.85%
Operating Profit -$832.7K -$726.7K
YoY Change 39.81% -95.87%
Interest Expense -$40.00K $56.91K
YoY Change -163.65% -9.42%
% of Operating Profit
Other Income/Expense, Net -$75.08K -$66.53K
YoY Change 18.34% -110.88%
Pretax Income -$907.8K -$793.3K
YoY Change 37.74% -95.33%
Income Tax $13.31K $48.81K
% Of Pretax Income
Net Earnings -$921.1K -$842.1K
YoY Change 70.3% -93.88%
Net Earnings / Revenue -3.58% -3.15%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.10 -$0.10
COMMON SHARES
Basic Shares Outstanding 8.893M shares 8.786M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.500M $7.775M
YoY Change 67.94% 8.11%
Cash & Equivalents $8.458M $7.775M
Short-Term Investments
Other Short-Term Assets $1.403M $1.105M
YoY Change -52.09% -60.4%
Inventory $494.1K $307.4K
Prepaid Expenses
Receivables $8.912M $8.951M
Other Receivables $0.00 $0.00
Total Short-Term Assets $28.73M $31.43M
YoY Change 0.55% 3.78%
LONG-TERM ASSETS
Property, Plant & Equipment $857.9K $888.9K
YoY Change -19.27% -22.9%
Goodwill $5.812M $5.812M
YoY Change 0.0% 0.0%
Intangibles $7.134M $6.673M
YoY Change 7.47% 4.91%
Long-Term Investments
YoY Change
Other Assets $1.557M $2.425M
YoY Change -46.9% -13.02%
Total Long-Term Assets $19.66M $20.27M
YoY Change -33.63% -31.2%
TOTAL ASSETS
Total Short-Term Assets $28.73M $31.43M
Total Long-Term Assets $19.66M $20.27M
Total Assets $48.39M $51.71M
YoY Change -16.85% -13.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.86M $13.38M
YoY Change -8.26% -8.96%
Accrued Expenses $10.62M $13.85M
YoY Change 24.29% 41.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.32M $30.56M
YoY Change 4.14% 12.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.500M $4.884M
YoY Change -2.1% -15.25%
Total Long-Term Liabilities $5.500M $4.884M
YoY Change -2.1% -15.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.32M $30.56M
Total Long-Term Liabilities $5.500M $4.884M
Total Liabilities $32.83M $35.45M
YoY Change 3.08% 7.86%
SHAREHOLDERS EQUITY
Retained Earnings -$85.82M -$84.90M
YoY Change 15.64% 15.24%
Common Stock $8.894K $8.894K
YoY Change 1.93% -99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.56M $16.26M
YoY Change
Total Liabilities & Shareholders Equity $48.39M $51.71M
YoY Change -16.85% -13.47%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$921.1K -$842.1K
YoY Change 70.3% -93.88%
Depreciation, Depletion And Amortization $780.0K $771.7K
YoY Change 186.55% 181.56%
Cash From Operating Activities $820.0K $3.510M
YoY Change -185.2% 159.16%
INVESTING ACTIVITIES
Capital Expenditures $260.0K $358.7K
YoY Change -128.5% -130.74%
Acquisitions
YoY Change
Other Investing Activities $330.0K $143.1K
YoY Change
Cash From Investing Activities $60.00K -$215.5K
YoY Change -106.58% -81.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -160.0K -129.9K
YoY Change 6.98% -13.27%
NET CHANGE
Cash From Operating Activities 820.0K 3.510M
Cash From Investing Activities 60.00K -215.5K
Cash From Financing Activities -160.0K -129.9K
Net Change In Cash 720.0K 3.165M
YoY Change -135.57% 8278.69%
FREE CASH FLOW
Cash From Operating Activities $820.0K $3.510M
Capital Expenditures $260.0K $358.7K
Free Cash Flow $560.0K $3.151M
YoY Change -1216.65% 24.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
-14152107 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16277000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-311 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
592544 usd
us-gaap Share Based Compensation
ShareBasedCompensation
269126 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-54040 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
27161 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25535 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
614914 usd
us-gaap Revenues
Revenues
52036538 usd
us-gaap Revenues
Revenues
45493781 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
22853220 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
19737710 usd
us-gaap Cost Of Revenue
CostOfRevenue
44316961 usd
us-gaap Gross Profit
GrossProfit
7216369 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1137792 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
855384 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48812 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55114 usd
wyy Common Stock Repurchased
CommonStockRepurchased
818211 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1010585 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
594456 usd
us-gaap Cost Of Revenue
CostOfRevenue
38277412 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001034760
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2045714 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8725476 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8893220 shares
CY2022Q4 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2023Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
56300 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33035
dei Entity Registrant Name
EntityRegistrantName
WidePoint Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2040275
dei Entity Address Address Line1
EntityAddressAddressLine1
11250 Waples Mill Road
dei Entity Address Address Line2
EntityAddressAddressLine2
South Tower 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfax
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22030
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
349-2577
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
WYY
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8893220 shares
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
508025 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
306938 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3909637 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
3319644 usd
us-gaap Gross Profit
GrossProfit
7719577 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
542172 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
562623 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1063850 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
95454 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
89385 usd
us-gaap Share Based Compensation
ShareBasedCompensation
235570 usd
us-gaap Share Based Compensation
ShareBasedCompensation
269126 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3830513 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3817316 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7741333 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7562545 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16277000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16277000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
263684 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
274088 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
529527 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
538449 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
4636369 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
20931027 usd
us-gaap Operating Expenses
OperatingExpenses
9334710 usd
us-gaap Operating Expenses
OperatingExpenses
25515786 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-726732 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17611383 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1615133 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18299417 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
9245 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
4158 usd
us-gaap Interest Income Other
InterestIncomeOther
11441 usd
us-gaap Interest Income Other
InterestIncomeOther
10728 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
56910 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
62826 usd
us-gaap Interest Expense
InterestExpense
115688 usd
us-gaap Interest Expense
InterestExpense
126347 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18864 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
669990 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19058 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
971003 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-66529 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
611322 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-123305 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-793261 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17000061 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1738438 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17444033 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3240852 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3291927 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-842073 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13759209 usd
us-gaap Net Income Loss
NetIncomeLoss
-1793552 usd
us-gaap Net Income Loss
NetIncomeLoss
-14152106 usd
CY2023Q2 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.10
CY2022Q2 wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-1.58
wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.20
wyy Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-1.62
CY2023Q2 wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8794704 shares
CY2022Q2 wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8696111 shares
wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8767163 shares
wyy Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8739043 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-842073 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13759209 usd
us-gaap Net Income Loss
NetIncomeLoss
-1793552 usd
us-gaap Net Income Loss
NetIncomeLoss
-14152106 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32404 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-134854 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
69652 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-139689 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
32404 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-134854 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
69652 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-139689 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-809669 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13894063 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1723900 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14291795 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7775113 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7530864 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
68549 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
51666 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8950712 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9277109 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
13603405 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
10244101 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1104513 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
935978 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
31433743 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27988052 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
888875 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978218 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4386323 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4723899 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6672593 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7398160 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5811578 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5811578 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
88420 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86909 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2424524 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2025845 usd
CY2023Q2 us-gaap Assets
Assets
51706056 usd
CY2022Q4 us-gaap Assets
Assets
49012661 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13375808 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12515081 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13845293 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11327269 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2725898 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1704933 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
615783 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596529 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30562782 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26143812 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4476849 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4745909 usd
CY2023Q2 wyy Contingent Consideration
ContingentConsideration
6900 usd
CY2022Q4 wyy Contingent Consideration
ContingentConsideration
6900 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
400280 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
364837 usd
CY2023Q2 us-gaap Liabilities
Liabilities
35446811 usd
CY2022Q4 us-gaap Liabilities
Liabilities
31261458 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2045714 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8893220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8725476 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8894 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8726 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101425959 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101194185 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-280582 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350234 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84895026 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83101474 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16259245 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51706056 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49012661 usd
us-gaap Profit Loss
ProfitLoss
-1793552 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3176568 usd
us-gaap Depreciation
Depreciation
532557 usd
us-gaap Depreciation
Depreciation
540361 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
34037 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1007555 usd
us-gaap Share Based Compensation
ShareBasedCompensation
235570 usd
wyy Warrants Expense
WarrantsExpense
0 usd
wyy Warrants Expense
WarrantsExpense
108000 usd
wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
0 usd
wyy Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-967000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3211 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2158825 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3118288 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-85066 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-134346 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
532882 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28272 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2197714 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1968727 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-154418 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1049118 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-312606 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-358000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1020975 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4179844 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103014 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
214096 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1936687 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
143116 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-574812 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2150783 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6493284 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6493284 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
255436 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
297132 usd
wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
3628 usd
wyy Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards
WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards
49224 usd
wyy Common Stock Repurchased
CommonStockRepurchased
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-259064 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1164567 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57150 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-152389 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
244249 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
712105 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7530864 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6479980 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7775113 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7192085 usd
us-gaap Interest Paid Net
InterestPaidNet
115019 usd
us-gaap Interest Paid Net
InterestPaidNet
124854 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27559 usd
wyy Capitalized Hardware And Software Development Costs In Accounts Payable
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayable
77873 usd
wyy Capitalized Hardware And Software Development Costs In Accounts Payable
CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayable
151995 usd
wyy Leased Assets And Lease Liabilities Terminated
LeasedAssetsAndLeaseLiabilitiesTerminated
0 usd
wyy Leased Assets And Lease Liabilities Terminated
LeasedAssetsAndLeaseLiabilitiesTerminated
876281 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41675995 usd
CY2022Q1 wyy Common Stock Repurchased Shares
CommonStockRepurchasedShares
-818211 usd
CY2022Q1 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
-49224 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
108000 usd
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
179741 usd
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-4835 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-392897 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
40698569 usd
CY2022Q2 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
0 usd
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
89385 usd
CY2022Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-134854 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13759209 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
26893891 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17751203 usd
CY2023Q1 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
-3628 usd
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
140116 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
37248 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-951479 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16973460 usd
CY2023Q2 wyy Issuance Of Common Stock Restricted Amount
IssuanceOfCommonStockRestrictedAmount
0 usd
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
95454 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
32404 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-842073 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16259245 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring use of estimates and judgment relate to revenue recognition, allowance for credit losses, ability to realize intangible assets and goodwill, ability to realize deferred income tax assets, fair value of certain financial instruments and the evaluation of contingencies and litigation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates. There were no significant changes in accounting estimates used by management during the quarter.</p>
wyy Significant Accounting Policies
SignificantAccountingPolicies
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">There were no significant changes in the Company’s significant accounting policies during the first six months of 2023 from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 31, 2023.</p>
CY2023Q2 wyy Contingent Consideration Cash Settled
ContingentConsiderationCashSettled
6500 usd
CY2023Q2 wyy Other Accrued Expenses
OtherAccruedExpenses
107862 usd
CY2022Q1 wyy Other Accrued Expenses
OtherAccruedExpenses
81662 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13845293 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5811578 usd
CY2023Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
239500 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
692800 usd
CY2022Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1100000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1900000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
506500 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
305900 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1007600 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
592500 usd
wyy Net Paid Percentage
NetPaidPercentage
0.90 pure
CY2023Q2 wyy Receivable Sold
ReceivableSold
1580000 usd
CY2023Q2 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
1560000 usd
CY2023Q2 wyy Outstanding Payment Balance
OutstandingPaymentBalance
4000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.05 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.03 pure
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23800000000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q2 wyy Common Stock Par Value
CommonStockParValue
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8893220 shares
CY2023Q2 wyy Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.33
CY2019Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2500000 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
56300 shares
CY2023Q2 wyy Unrecognized Share Based Expense
UnrecognizedShareBasedExpense
44900 usd
us-gaap Insured Financial Obligations With Credit Deterioration Remaining Weighted Average Contract Period
InsuredFinancialObligationsWithCreditDeteriorationRemainingWeightedAverageContractPeriod
P0Y10M24D
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-842073 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13759209 usd
us-gaap Net Income Loss
NetIncomeLoss
-1793552 usd
us-gaap Net Income Loss
NetIncomeLoss
-14152106 usd
CY2023Q2 wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8794704 shares
CY2022Q2 wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8696111 shares
wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8767163 shares
wyy Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
8739043 shares
CY2023Q2 wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-0.10
CY2022Q2 wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-1.58
wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-0.20
wyy Basic And Diluted Loss Per Shares
BasicAndDilutedLossPerShares
-1.62
CY2023Q2 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
28675 shares
CY2022Q2 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
7124 shares
CY2023Q2 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
CY2022Q2 wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
31774 shares
us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
30402 shares
wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
wyy Warrantsto Purchasec Cmmon Shares Outstanding
WarrantstoPurchasecCmmonSharesOutstanding
150000 shares
CY2023Q2 us-gaap Revenues
Revenues
26762857 usd
CY2022Q2 us-gaap Revenues
Revenues
23057354 usd
us-gaap Revenues
Revenues
52036538 usd
us-gaap Revenues
Revenues
45493781 usd
CY2023Q2 us-gaap Revenues
Revenues
26762857 usd
CY2022Q2 us-gaap Revenues
Revenues
23057354 usd
us-gaap Revenues
Revenues
52036538 usd
us-gaap Revenues
Revenues
45493781 usd
CY2023Q2 us-gaap Revenues
Revenues
26762857 usd
CY2022Q2 us-gaap Revenues
Revenues
23057354 usd
us-gaap Revenues
Revenues
52036538 usd
us-gaap Revenues
Revenues
45493781 usd
CY2023Q2 wyy Revenue Related Approximately
RevenueRelatedApproximately
534200 usd
CY2022Q2 wyy Revenue Related Approximately
RevenueRelatedApproximately
580100 usd
wyy Revenue Related Approximately
RevenueRelatedApproximately
1243600 usd
wyy Revenue Related Approximately
RevenueRelatedApproximately
1660000 usd

Files In Submission

Name View Source Status
0001654954-23-010759-index-headers.html Edgar Link pending
0001654954-23-010759-index.html Edgar Link pending
0001654954-23-010759.txt Edgar Link pending
0001654954-23-010759-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wyy-20230630.xsd Edgar Link pending
wyy_10q.htm Edgar Link pending
wyy_ex311.htm Edgar Link pending
wyy_ex312.htm Edgar Link pending
wyy_ex32.htm Edgar Link pending
wyy-20230630_cal.xml Edgar Link unprocessable
wyy-20230630_def.xml Edgar Link unprocessable
wyy-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
wyy-20230630_lab.xml Edgar Link unprocessable
wyy_10q_htm.xml Edgar Link completed